Sofiva GenomicsLtd Dividends and Buybacks
Dividend criteria checks 0/6
Sofiva GenomicsLtd is a dividend paying company with a current yield of 0.5%.
Key information
0.5%
Dividend yield
-1.4%
Buyback Yield
Total Shareholder Yield | -0.9% |
Future Dividend Yield | n/a |
Dividend Growth | -7.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | NT$0.200 |
Payout ratio | 20% |
Recent dividend and buyback updates
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 6615 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.
Growing Dividend: 6615 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
Sofiva GenomicsLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (6615) | 0.5% |
Market Bottom 25% (TW) | 1.8% |
Market Top 25% (TW) | 4.6% |
Industry Average (Healthcare) | 3.2% |
Analyst forecast (6615) (up to 3 years) | n/a |
Notable Dividend: 6615's dividend (0.5%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.8%).
High Dividend: 6615's dividend (0.5%) is low compared to the top 25% of dividend payers in the TW market (4.58%).
Earnings Payout to Shareholders
Earnings Coverage: 6615 is not paying a notable dividend for the TW market.
Cash Payout to Shareholders
Cash Flow Coverage: 6615 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 09:54 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sofiva Genomics Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yenya Kuo | Capital Securities Corporation |
Xiaowei Huang | Masterlink Securities Corp. |